Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 04 May, 2017

GlaxoSmithKline PLC

Result of AGM

RNS Number : 2573E
GlaxoSmithKline PLC
04 May 2017
 

GlaxoSmithKline plc

 

 Result of AGM

 

GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') today, all resolutions were passed by shareholders. The full text of each resolution is contained in the 2017 Notice of AGM, which is available on the GSK website, www.gsk.com

 

GSK AGM Poll Results

 

The following table shows the total number of votes cast for each resolution:

 

Resolution

Total votes for*

%

Total votes against

%

Total votes cast

Votes withheld**

1

To receive and adopt the 2016 Annual Report

3,554,183,464

97.22

101,455,389

2.78

3,655,638,853

4,387,214

2

Approve the Annual report on remuneration

3,463,239,643

96.39

129,558,994

3.61

3,592,798,637

67,227,431

3

Approve the Remuneration policy

3,422,452,218

95.23

171,330,252

4.77

3,593,782,470

66,243,598

4

Election of Emma Walmsley

3,634,697,039

99.38

22,652,327

0.62

3,657,349,366

2,676,702

5

Election of Dr Vivienne Cox

3,585,205,455

98.03

72,167,674

1.97

3,657,373,129

2,653,239

6

To elect Dr Patrick Vallance

3,629,796,597

99.25

27,494,401

0.75

3,657,290,998

2,735,337

7

Re-election of Sir Philip Hampton

3,628,585,104

99.22

28,393,827

0.78

3,656,978,931

3,047,437

8

Re-election of Professor Sir Roy Anderson

3,625,292,635

99.12

32,058,752

0.88

3,657,351,387

2,674,980

9

Re-election of Vindi Banga

3,581,285,228

97.92

76,000,048

2.08

3,657,285,276

2,741,092

10

Re-election of Simon Dingemans

3,518,149,283

96.20

139,147,225

3.80

3,657,296,508

2,729,860

11

Re-election of Lynn Elsenhans

3,638,701,603

99.49

18,607,222

0.51

3,657,308,825

2,710,187

12

Re-election of Dr Jesse Goodman

3,639,142,174

99.50

18,139,405

0.50

3,657,281,579

2,714,188

13

Re-election of Judy Lewent

3,510,396,677

95.98

146,948,919

4.02

3,657,345,596

2,680,772

14

Re-election of Urs Rohner

3,575,150,146

97.76

82,080,983

2.24

3,657,231,129

2,795,239

15

Re-appointment of auditors

3,589,897,930

98.70

47,405,837

1.30

3,637,303,767

22,722,600

16

Remuneration of auditors

3,634,255,503

99.37

23,089,499

0.63

3,657,345,002

2,674,361

17

Authority for the company to make donations to political organisations and incur political expenditure

3,590,068,747

98.21

65,556,654

1.79

3,655,625,401

4,400,967

18

Authority to allot shares

3,545,752,292

96.96

111,083,355

3.04

3,656,835,647

3,190,721

19

Disapplication of pre-emption rights - general power***

3,579,962,643

97.94

75,432,563

2.06

3,655,395,206

4,624,157

20

Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***

3,395,638,484

92.96

257,114,976

7.04

3,652,753,460

7,265,904

21

Authority for the company to purchase its own shares***

3,607,672,499

98.68

48,202,613

1.32

3,655,875,112

4,151,256

22

Exemption from statement of senior statutory auditor's name

3,629,354,814

99.28

26,480,369

0.72

3,655,835,183

4,198,037

23

Authorise reduced notice of a general meeting other than an AGM***

3,407,170,884

93.19

248,934,681

6.81

3,656,105,565

3,920,802

24

Approve the GlaxoSmithKline 2017 Performance Share Plan

3,515,643,781

96.16

140,281,237

3.84

3,655,925,018

4,101,350

25

Approve the 2017 GlaxoSmithKline Deferred Annual Bonus Plan

3,579,310,888

97.97

74,224,589

2.03

3,653,535,477

6,490,891

 

Notes:

*

Includes discretionary votes.

**

A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

***

Indicates Special Resolutions requiring a 75% majority.

 

The following table provides further relevant information:

 


 

GSK's

Seventeenth

AGM

(2017)

 

GSK's

Sixteen AGM

(2016)

 

Issued share capital (excluding Treasury Shares)

4,917,502,476

4,871,555,095

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

74.43%

76.15%

Total shareholder population

116,502

132,85

Total number of proxies lodged

7,336

8,020

% of shareholders who lodged proxies

6.30%

6.03%

Number of shareholders, corporate representatives and proxies who attended the AGM

435

448

 

V A Whyte

Company Secretary

4 May 2017

 

These results will shortly be available on the company's website at www.gsk.com.

 

 

GSK enquiries:

 




UK Media enquiries:

David Mawdsley

+44 (0) 20 8047 5502

(London)


Simon Steel

+44 (0) 20 8047 5502

(London)





US Media enquiries:

Sarah Alspach

+1 202 715 1048

(Washington)


Sarah Spencer

+1 215 751 3335

(Philadelphia)





Analyst/Investor enquiries:

Sarah Elton-Farr

+44 (0) 20 8047 5194

(London)


Gary Davies

+44 (0) 20 8047 5503

(London)


James Dodwell

+44 (0) 20 8047 2406

(London)


Sarah Webster

+44 (0) 20 8047 0246

(London)


Tom Curry

+1 215 751 5419

(Philadelphia)


Jeff McLaughlin

+1 215 751 7002

(Philadelphia)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGOKQDDOBKDKPK

a d v e r t i s e m e n t